Pictet Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.4M | Buy |
1,584,534
+1,149,578
| +264% | +$25M | 0.04% | 387 |
|
|
2025
Q1 | $7.42M | Sell |
434,956
-32,487
| -7% | -$554K | 0.01% | 728 |
|
|
2024
Q4 | $8.58M | Sell |
467,443
-37,281
| -7% | -$684K | 0.01% | 704 |
|
|
2024
Q3 | $7.92M | Sell |
504,724
-7,966
| -2% | -$125K | 0.01% | 714 |
|
|
2024
Q2 | $8.33M | Sell |
512,690
-795,068
| -61% | -$12.9M | 0.01% | 669 |
|
|
2024
Q1 | $24M | Sell |
1,307,758
-153,474
| -11% | -$2.82M | 0.03% | 460 |
|
|
2023
Q4 | $45.8M | Buy |
1,461,232
+109,635
| +8% | +$3.43M | 0.05% | 326 |
|
|
2023
Q3 | $28.2M | Buy |
+1,351,597
| New | +$28.2M | 0.03% | 384 |
|